Association between progranulin and β-amyloid in dementia with Lewy bodies

American Journal of Alzheimer's Disease and other Dementias

Volumn 23, Issue 5, 2008, Pages 488-493

  Revuelta, Gonzalo J ^a   Rosso, Andrea ^a   Lippa, Carol F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Dementia with Lewy bodies; Frontotemporal dementia; Progranulin; Synucleinopathies; amyloid

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; PROGRANULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MALE; MICROGLIA; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TEMPORAL LOBE;

EID: 54049135189     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317508321910     Document Type: Article

References (20)

1. Ong CHP, He Z., Kriazhev L., Shan X., Palfree RG, Bateman A. Regulation of progranulin expression in myeloid cells. Am J Physiol Regul Integr Comp Physiol. 2006 ; 291: 1602-1612.
2. Pickering-Brown SM Progranulin and frontotemporal lobar degeneration. Acta Neuropathol. 2007 ; 114: 39-47.
3. Baker M., Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006 ; 442: 916-919.
4. Boeve BF, Baker M., Dickson DW, et al. Frontotemporal dementia and parkinsonism associated with the IVS1 + 1G->A mutation in progranulin: a clinicopathologic study. Brain. 2006 ; 129: 3103-3114.
5. Cruts M., Gijselinck I., van der Zee J., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006 ; 442: 920-924.
6. Huey ED, Grafman J., Wassermann EM, et al. Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol. 2006 ; 60: 374-380.
7. Mukherjee O., Pastor P., Cairns NJ, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006 ; 60: 314-322.
8. Neumann M., Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006 ; 314: 130-133.
9. Arai T., Nonaka T., Hasegawa M., et al. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett. 2003 ; 342: 41-44.
10. McKeith IG, Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 ; 47: 1113-1124.
11. Dodson SE, Gearing M., Lippa CF, Montine TJ, Levey AI, Lah JJ LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol. 2006 ; 65: 866-872.
12. Lippa SM, Lippa CF, Mori H. Alpha-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of β-amyloid plaque level. Am J Alzheimers Dis Other Demen. 2005 ; 20: 315-18.
13. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006 ; 112: 389-404.
14. McKeith IG, Dickson DW, Lowe J., et al. Diagnosis and management of dementia with Lewy bodies, Third report of the DLB consortium. Neurology. 2005 ; 65: 1864-1872.
15. Leverenz JB, Yu CE, Montine TJ, et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain. 2007 ; 130: 1360-1374.
16. Baker CA, Martin D., Manuelidis L. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol. 2002 ; 76: 10905-10913.
17. Ohmi K., Greenberg DS, Rajavel KS, Ryazantsev S., Li HH, Neufeld EF Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A. 2003 ; 100: 1902-1907.
18. Smith WW, Gorospe M., Kusiak JW Signaling mechanisms underlying Abeta toxicity: potential therapeutic targets for Alzheimer's disease. CNS Neurol Disord Drug Targets. 2006 ; 5: 355-361.
19. Trojanowski JQ, Lee VM The role of tau in Alzheimer's disease. Med Clin North Am. 2002 ; 86: 615-627.
20. He Z., Ong CH, Halper J., Bateman A. Progranulin is a mediator of the wound response. Nat Med. 2003 ; 9: 225-229.